Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)
Clinical trial NCT04682405 · COMPLETED
Trial details
- NCT number
- NCT04682405
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2022-11-11
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.